Back
ESC Premium Access

Effect of pretreatment with P2Y12 receptor antagonists on mortality in patients undergoing PCI: A report from SCAAR

Session: Poster session 2 - Clinical platelet studies
Topic: Thrombosis and platelets
Speaker: Professor E. Omerovic (Gothenburg, SE)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Professor Elmir Omerovic

Sahlgrenska University Hospital, Gothenburg (Sweden)
13 presentations
0 follower

24 more presentations in this session

Gender differences in oral antiplatelet treatment use - results from a nationwide cohort study of acute coronary syndrome patients in Finland

Speaker: Doctor V. Kyto (Turku, FI)

Access
Abstract
Slides
Thumbnail

Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome

Speaker: Doctor M. Faggioni (Philadelphia, US)

Access
Abstract
Thumbnail

Platelet reactivity and outcomes after transcatheter aortic valve implantation

Speaker: Doctor L. Gross (Munich, DE)

Access
Abstract
Slides
Thumbnail

Safety of a regional standardized protocol to optimize the use of most effective platelet inhibition in ACS treated with PCI : Final Results from the Multicenter Rijnmond Collective Cardiology Study

Speaker: Doctor M. Van Der Linden (Schiedam, NL)

Access
Abstract
Slides
Thumbnail

Characteristics and safety outcomes in first-time users of the P2Y12 receptor antagonists clopidogrel, prasugrel and ticagrelor

Speaker: Associate Professor S. Johansson (Molndal, SE)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster session 2 - Clinical platelet studies

Speakers: Professor E. Omerovic, Doctor V. Kyto, Doctor M. Faggioni, Doctor L. Gross, Doctor M. Van Der Linden...
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb